Featured Article

May 14, 2025

5 minutes with… Andrew Cooper, CEO, CluePoints

Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven culture and what it takes to lead with innovation and teamwork

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Blog

What Sponsors Actually Look for in CRO RBQM

And why inspection readiness is now a commercial differentiator. RBQM is often discussed as a regulatory...

Blog

From Fragmentation to a Scalable RBQM Operating Model

Why tools alone aren’t enough, and what CROs need instead. Most CROs don’t lack RBQM capability....

Blog

Monitoring Isn’t a Cost Problem. It’s a Margin Lever.

Why CROs need to rethink monitoring, not reduce it. For years, the conversation around monitoring has...